Impact of Pharmacist Intervention on Improving the Quality of Life of Patients with Type 2 Diabetes Mellitus

Authors

  • Shofian Syarifuddin Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • Azizah Nasution Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • Aminah Dalimunthe Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • - Khairunnisa Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2019.140

Keywords:

Antihyperglycemic, 36-item short form, Pharmacist intervention, QOL, T2DM.

Abstract

AIM: To analyse the characteristics, and analyse the impact of pharmacist intervention on quality of life (QOL) outpatients with type 2 diabetes mellitus (T2DM).

METHODS: This six-month analytical cohort study was conducted by assessing the patients’ characteristics and their quality of life by distributing a questionnaire, and the 36-Item short form instrument to the patients with T2DM (n = 45) admitted to the Tertiary hospital in Tebing Tinggi. Patients who had mental disorders, HIV-AIDS, liver disease, stage 4 chronic kidney disease, and pregnant women were excluded from the study. The patients’ quality of life was measured before and after interventions and analysed using the paired t-test. All analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 22, Chicago, IL, USA) (p < 0.05 was considered significant).

RESULTS: The mean age of the patients was 61.96 ± 6.45 (years). Most (66.7%) of them were females. The mean QOL (in the score) of the patients: before the intervention, 61.07 ± 15.13; after the intervention, 70.15 ± 14.23, there was a significant difference between groups with and without interventions, p < 0.001.

CONCLUSION: Active contribution of pharmacists in the management of T2DM patients is urgent and important to improve the patients’ QOL.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

WHO, 2016. Available at: http://www.who.int/features/factfiles/diabetes/en/ (Accessed 25 October 2018).

International Diabetes Federation. The IDF Western Pacific Region, 2018. Available at: https://www.idf.org/our-network/regions-members/western-pacific/members/104-indonesia. (Accessed 20 October 2018).

WHO. Global Report on Diabetes, 2016. Available at: http://www.who.int/diabetes/global-report/en/ (Accessed 19 October 2018).

Lopez JM, Annunziata K, Bailey RA, Rupnow MF, Morisky DE. Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. Patient preference and adherence. 2014; 8:683. https://doi.org/10.2147/PPA.S58813 PMid:24855344 PMCid:PMC4020884

Sutiawati M, Nurhaedar J, Yustini. 2013. The influence of diet education on knowledge, eating patterns, and blood glucose level in patients with type 2 diabetes mellitus Lanto'DG Pasewang Jeneponto Hospital. Makassar, 2018. Available at: portalgaruda.org/article.php.article-29748&val=2168. (Assessed 25 October 2018).

Ningtyas DW, Pudjo W, Irma P. Analysis of quality of life of patients with type 2 diabetes melitus in Bangil public hospital, district of Pasuruan. Jember, 2013. Available at: http://repository.unej.ac.id/handle/123456789/59225. (Accessed 25 October 2018).

Davis TM, Clifford RM, Davis WA, Batty KT. The role of pharmaceutical care in diabetes management. Br J Diabetes Vasc Dis. 2005; 5:352-6. https://doi.org/10.1177/14746514050050061001

Khan CR, Weir GC, King GL, Moses AC. Joslin's Diabetes Mellitus. (14th ed.). Philadelphia: Lippincott Williams & Wilkins, 2005.

Jaber L, Halapy H, Fenret M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996; 30:238-43. https://doi.org/10.1177/106002809603000305 PMid:8833557

Sadur C, Moline N, Costa M, et al. Diabetes management in a health maintenance organization: efficacy of care management using cluster visits. Diab. Care. 1999; 22:2011-7. https://doi.org/10.2337/diacare.22.12.2011

Majumdar S, Guirguis L, Toth E, et al. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type2 diabetes. Diab. Care. 2003; 26:3061-6. https://doi.org/10.2337/diacare.26.11.3061

Coast-Senior E, Kroner B, Kelley C, Trili L. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998; 32:636-41. https://doi.org/10.1345/aph.17095 PMid:9640480

Hawkins D, Bradberry JC, Cziraky MJ, et al. National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: toward better patient outcomes and new roles for pharmacists. Pharmacotherapy. 2002; 22:436-44. https://doi.org/10.1592/phco.22.7.436.33667 PMid:11939679

Rand Health Care, 36-Item Short Form Survey (SF-36), 2017. Available at: https://www.rand.org/health/surveys_tools/mos/36-item-short-form.html (Accessed 26 December 2017).

American Diabetes Association, 2018. Available at: http://www.diabetes.org/living-with-diabetes/treatment-and-care/seniors/living-healthy-with-diabetes.html (Accessed 11 February 2018).

Nasution A, Simbolon RC, Tanjung HR. Characteristics, antihyperglycemics utilization, and quality of life in patients with type 2 diabetes mellitus admitted to primary health center. IJPCR. 2018; 01:01-10.

Kandasamy K, Konakalla M, Sam R, et al. A Pilot study on the impact of pharmacist intervention in type-2 diabetes mellitus counselling program in a Rural Community. Indian J Pharm Sci. 2017; 79(5):701-706. https://doi.org/10.4172/pharmaceutical-sciences.1000282

Awodele O, Osuolale JA. Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African health sciences. 2015; 15(2):513-22. https://doi.org/10.4314/ahs.v15i2.26 PMid:26124798 PMCid:PMC4480454

Central Agency on Statistics (Badan Pusat statistik). 2016. Total population and sex ratio according to ditricts in Tebing Tinggi city, 2917. Available at: https://tebingtinggikota.bps.go.id/statictable/2017/11/21/16/jumlah-penduduk-dan-rasio-jenis-kelamin-menurut-kecamatan-di-kota-tebing-tinggi-2016.html (Accessed 19 October 2018).

Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations Between Trends in Race/Ethnicity, Aging, and Body Mass Index With Diabetes Prevalence in the United States. A Series of Cross-sectional Studies Increase in Diabetes Prevalence Over Time. Ann Intern Med. 2014; 161(5):328-35. https://doi.org/10.7326/M14-0286 PMid:25178569

Huerta JM, Tormo MJ, Chirlaque MD, Gavrila D, Amiano P, Arriola L, Ardanaz E, Rodríguez L, Sánchez MJ, Mendez M, Salmerón D. Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study. BMC Endocr Disord. 2013; 13(1):7. https://doi.org/10.1186/1472-6823-13-7 PMid:23388074 PMCid:PMC3575248

American Diabetes Association. Standards of Medical Care in Diabetes, 2004. Available from: Diabetesjournals.org. Assessed on 25th Sept 2018.

American Diabetes Association. Pharmacologic approache to glycemic treatment: Standards of medical care in diabetes. Diab. care; 2018; 41(Suppl.1):S73-S85. https://doi.org/10.2337/dc18-S008

Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016; 164(11):740-51. https://doi.org/10.7326/M15-2650 PMid:27088241

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2013; 2(4):485-91. https://doi.org/10.5455/2319-2003.ijbcp20130826

Mandal S, Maiti T, Das AK, Das A, Mandal A, Sarkar BS, Mandal S. Drug utilization study in patients with type 2 diabetes mellitus attending diabetes clinic of a tertiary care hospital in rural Bengal. Int J Basic Clin Pharmacol. 2016; 5(4):1647-54. https://doi.org/10.18203/2319-2003.ijbcp20162487

Shareef J, Fernandez J, Samaga L. Impact of Pharmacist's Intervention on Improving Quality of Life in Patients with Diabetes Mellitus. J Diabetes Metab Disord Control. 2016; 3(4):83-88. https://doi.org/10.15406/jdmdc.2016.03.00076

Maw, WM, et al. The Effect of Pharmaceutical care in the elderly patients with type 2 Diabetes Mellitus. Asian J Pharm Sci II. 2016:93-94. https://doi.org/10.1016/j.ajps.2015.11.119

Eikenhorst, L. van, Dijk, L. van, Taxis, K, Gier, H. de. Pharmacist-led self- management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Frontiers in Pharmacology. 2017; 8(891). https://doi.org/10.3389/fphar.2017.00891

Khan NA, Saxena S, Handa S, Habib A, Abid M, Patra A, et al. Impact of counseling on diabetic patients. Int J Pharm Clin Res. 2010; 2:72-5.

Ojieabu WA, Bello SI, Arute JE. Evaluation of pharmacists' educational and counselling impact on patients' clinical outcomes in a diabetic setting. J Diabetol. 2017; 8:7-11. https://doi.org/10.4103/jod.jod_5_17

Published

2019-05-01

How to Cite

1.
Syarifuddin S, Nasution A, Dalimunthe A, Khairunnisa -. Impact of Pharmacist Intervention on Improving the Quality of Life of Patients with Type 2 Diabetes Mellitus. Open Access Maced J Med Sci [Internet]. 2019 May 1 [cited 2024 Mar. 5];7(8):1401-5. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.140

Issue

Section

E - Public Health